Logos Global Management »

Verastem shares owned by Logos Global Management

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $36M 4.1M 8.83
2025-06-30 $4.2M 1.0M 4.15

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Verastem

Rtw Investments
Balyasny Asset Management
Logos Global Management
Point72 Asset Management
BlackRock
Vanguard Group
Stonepine Capital Management
Vivo Capital
Foresite Capital Management VI
State Street Corporation
Armistice Capital
Rosalind Advisors
Nantahala Capital Management
Geode Capital Management
Millennium Management

View all funds holding Verastem